SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950157-22-000976
Filing Date
2022-08-31
Accepted
2022-08-31 06:02:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A defa14a.htm DEFA14A 73433
  Complete submission text file 0000950157-22-000976.txt   74408
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37539 | Film No.: 221216199
SIC: 2834 Pharmaceutical Preparations